Elevated Hemoglobin A1c (HbA1c) in Adults without a History of Diabetes in the U.S.

  1. Elizabeth Selvin, PhD, MPH (lselvin{at}jhsph.edu)1,2,
  2. Hong Zhu, BS3 and
  3. Frederick L. Brancati, MD, MHS1,2
  1. 1 Department of Epidemiology and the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health
  2. 2 Division of General Internal Medicine, Department of Medicine, Johns Hopkins University, Baltimore, Maryland
  3. 3 Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health

    Abstract

    Objective: to examine the prevalence and correlates of elevated HbA1c in a large, nationally representative sample of adults without diabetes in the United States.

    Research Design and Methods: we analyzed data from 15,934 participants without diagnosed diabetes aged 20 and older who had HbA1c measurements in the 1999-2006 National Health and Nutrition Examination Survey (NHANES), a cross-sectional and nationally representative sample of the U.S. population.

    Results: The overall prevalence of HbA1c >6% was 3.8% corresponding to 7.1 million adults in the U.S. population. Approximately 90% of these individuals had fasting glucose ≥ 100 mg/dl. Older age, male gender, non-Hispanic black race/ethnicity, hypercholesterolemia, higher body mass index, and lower attained education were significantly associated with having a higher HbA1c level even among individuals with normal fasting glucose (<100 mg/dl) and after multivariable adjustment.

    Conclusions: A single elevated HbA1c level (HbA1c >6%) is common in the general population of adults without a history of diabetes and is highly reliable for the detection of elevated fasting glucose. Non-diabetic adults with elevated HbA1c are likely to have impaired fasting glucose and an array of other risk factors for type 2 diabetes and cardiovascular disease.

    Footnotes

      • Received September 16, 2008.
      • Accepted January 20, 2009.